Stereotactic Comparison Among Cerebral Blood Volume, Methionine Uptake, and Histopathology in Brain Glioma

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2007 Mar 14

PMID 17353312

Citations 43

Authors

N Sadeghi

I Salmon

C Decaestecker

M Levivier

T Metens

D Wikler

V Denolin

S Rorive

N Massager

D Baleriaux

S Goldman

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Vascularity, metabolism, and histologic grade are related in gliomas but the exact determinants of these relationships are not fully defined. We used image coregistration and stereotactic biopsies to regionally compare cerebral blood volume (CBV) and (11)C-methionine (MET) uptake measurements in brain gliomas and to assess their relationship by histopathologic examination.

Materials And Methods: Fourteen patients with brain gliomas underwent MR imaging, including dynamic susceptibility contrast-enhanced MR and positron-emission tomography (PET) using MET acquired in identical stereotactic conditions before biopsy. MR-based CBV maps were calculated and both CBV maps and PET images were coregistered to anatomic images. Sixty-five biopsy samples were obtained on trajectories targeted toward high MET uptake area. The following histopathologic features were semiquantified in each sample: mitotic activity, endothelial proliferation, cellular pleomorphism, and tumor necrosis. CBV and MET uptake values were measured in the biopsy area and normalized to contralateral white matter. CBV ratios were compared with MET uptake ratios, and both measurements were compared with histologic features of each sample.

Results: CBV ratios ranged from 0.08 to 10.24 (median = 1.73), and MET uptake ratios ranged from 0.30 to 4.91 (median = 1.67). There was a positive correlation between CBV ratios and MET uptake ratios (r = 0.65, P < .001). Both CBV and MET uptake ratios were found to be significantly related to endothelial proliferation and mitotic activity (P < .01).

Conclusion: Within glial tumors, there is a local relationship between CBV and MET uptake measurements. Both provide indices of focal malignant activity.

Citing Articles

Noninvasive assessment of Ki-67 labeling index in glioma patients based on multi-parameters derived from advanced MR imaging.

Hu Y, Zhang K Front Oncol. 2024; 14:1362990.

PMID: 38826787 PMC: 11140042. DOI: 10.3389/fonc.2024.1362990.

Assessment of Brain Tumour Perfusion Using Early-Phase F-FET PET: Comparison with Perfusion-Weighted MRI.

Filss C, Cramer J, Loher S, Lohmann P, Stoffels G, Stegmayr C Mol Imaging Biol. 2023; 26(1):36-44.

PMID: 37848641 PMC: 10827807. DOI: 10.1007/s11307-023-01861-2.

T2-FLAIR mismatch sign correlates with C-methionine uptake in lower-grade diffuse gliomas.

Ebiko Y, Tamura K, Hara S, Inaji M, Tanaka Y, Nariai T J Neurooncol. 2023; 164(1):257-265.

PMID: 37589920 DOI: 10.1007/s11060-023-04417-0.

Methionine deprivation inhibits glioma growth through downregulation of CTSL.

Qian F, Xu H, Zhang Y, Li L, Yu R Am J Cancer Res. 2022; 12(11):5004-5018.

PMID: 36504894 PMC: 9729907.

Voxelwise Principal Component Analysis of Dynamic [S-Methyl-C]Methionine PET Data in Glioma Patients.

Martens C, Debeir O, Decaestecker C, Metens T, Lebrun L, Leurquin-Sterk G Cancers (Basel). 2021; 13(10).

PMID: 34066294 PMC: 8152079. DOI: 10.3390/cancers13102342.

References

Goldman S, Levivier M, Pirotte B, BRUCHER J, Wikler D, Damhaut P . Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med. 1997; 38(9):1459-62. View

Heiss P, Mayer S, Herz M, Wester H, Schwaiger M, Senekowitsch-Schmidtke R . Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 1999; 40(8):1367-73. View

Chung J, Kim Y, Kim S, Lee Y, Paek S, Yeo J . Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002; 29(2):176-82. DOI: 10.1007/s00259-001-0690-4. View

Wienhard K, Herholz K, Coenen H, Rudolf J, Kling P, Stocklin G . Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. J Nucl Med. 1991; 32(7):1338-46. View

Weisskoff R, Rosen B . Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA). Magn Reson Med. 1992; 25(1):211-2. DOI: 10.1002/mrm.1910250122. View

Lev M, Ozsunar Y, Henson J, Rasheed A, Barest G, Harsh 4th G . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol. 2004; 25(2):214-21. PMC: 7974605. View

Braun V, Dempf S, Weller R, Schachenmayr W, Richter H . Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data -- results of a pilot study in 32 surgical cases. Acta Neurochir (Wien). 2002; 144(8):777-82; discussion 782. DOI: 10.1007/s00701-002-0942-5. View

van Gelderen P, Ramsey N, Liu G, Duyn J, Frank J, Weinberger D . Three-dimensional functional magnetic resonance imaging of human brain on a clinical 1.5-T scanner. Proc Natl Acad Sci U S A. 1995; 92(15):6906-10. PMC: 41439. DOI: 10.1073/pnas.92.15.6906. View

Rorden C, Brett M . Stereotaxic display of brain lesions. Behav Neurol. 2001; 12(4):191-200. DOI: 10.1155/2000/421719. View

10.

Kracht L, Friese M, Herholz K, Schroeder R, Bauer B, Jacobs A . Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging. 2003; 30(6):868-73. DOI: 10.1007/s00259-003-1148-7. View

11.

Pirotte B, Goldman S, Massager N, David P, Wikler D, Lipszyc M . Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg. 2004; 101(3):476-83. DOI: 10.3171/jns.2004.101.3.0476. View

12.

Maia Jr A, Malheiros S, da Rocha A, da Silva C, Gabbai A, Ferraz F . MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol. 2005; 26(4):777-83. PMC: 7977110. View

13.

Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P . Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging. 1997; 16(2):187-98. DOI: 10.1109/42.563664. View

14.

Tysnes B, Mahesparan R . Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol. 2001; 53(2):129-47. DOI: 10.1023/a:1012249216117. View

15.

De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M . Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg. 2001; 95(5):746-50. DOI: 10.3171/jns.2001.95.5.0746. View

16.

Levivier M, Goldman S, Pirotte B, BRUCHER J, Baleriaux D, Luxen A . Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg. 1995; 82(3):445-52. DOI: 10.3171/jns.1995.82.3.0445. View

17.

Comar D, CARTRON J, Maziere M, Marazano C . Labelling and metabolism of methionine-methyl-11 C. Eur J Nucl Med. 1976; 1(1):11-4. DOI: 10.1007/BF00253260. View

18.

Sato N, Suzuki M, Kuwata N, Kuroda K, Wada T, Beppu T . Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev. 2000; 22(4):210-4. DOI: 10.1007/s101430050018. View

19.

Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E . Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys. 2000; 48(1):43-52. DOI: 10.1016/s0360-3016(00)00604-0. View

20.

Weisskoff R, Zuo C, Boxerman J, Rosen B . Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med. 1994; 31(6):601-10. DOI: 10.1002/mrm.1910310605. View